Transdermal iontophoresis. Part II: Peptide and protein delivery

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 21, Issue 3, 1999, Pages 229-240

  Pillai, Omathanu ^a   Nair, Vinod ^a   Poduri, Ramarao ^a   Panchagnula, Ramesh ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Growth hormone releasing factor; Insulin; Luteinizing hormone releasing hormone; Peptides Proteins; Thyrotropin releasing hormone; Transdermal iontophoresis; Vasopressin

Indexed keywords

ALPHA INTERFERON; ARGIPRESSIN[DEGLYCINAMIDE]; ASPARAGINASE; ASPARTAME; BETA ENDORPHIN; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; BOVINE INSULIN; BUSERELIN; CALCITONIN; CHOLECYSTOKININ OCTAPEPTIDE; CHYMOPAPAIN; COLLAGENASE; CYCLOSPORIN; DESMOPRESSIN; GONADORELIN AGONIST; GROWTH HORMONE RELEASING FACTOR; HUMAN INSULIN; IMMUNOGLOBULIN; INSULIN; LEUPRORELIN; NAFARELIN; OCTREOTIDE; PIG INSULIN; PROTIRELIN; SALCATONIN; SYNTHETIC PEPTIDE; UNINDEXED DRUG; VACCINE; VASOPRESSIN;

DRUG DELIVERY SYSTEM; DRUG STABILITY; HUMAN; IONTOPHORESIS; MOLECULAR WEIGHT; NONHUMAN; PEPTIDE SYNTHESIS; PROTEIN SYNTHESIS; REVIEW; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0033014007     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.1999.21.3.534833     Document Type: Review

References (119)

1. Lee, V.H.L. Ophthalmic delivery of peptide and protein. Pharm Technol 1987, 11: 26-38.
2. Vane, J., Cuatrecasa, P. Genetic engineering and pharmaceuticals. Nature 1984, 312: 303-5.
3. Chien, Y.W., Siddiqui, O., Sun, Y, Shi, W.M., Liu, J.C. Transdermal iontophoretic delivery of therapeutic peptides/proteins (I) Insulin. In: Biological Approaches in Controlled Delivery of Drugs. Juliano, R.L. (Ed.). Ann NY Acad Sci 1987, 507: 32-51.
4. Banerjee, P.S., Hosny, E.A., Robinson, J.R. Parentral delivery of peptide and protein drugs. In: Peptide and Protein Drug Delivery. Lee, V.H.L. (Ed.). Marcel Dekker, Inc.: New York 1991, 487-543.
5. Nair, V., Pillai, O., Poduri, R., Panchagnula, R. Transdermal iontophoresis. Part I: Basic principles and considerations. Methods Find Exp Clin Pharmacol 1999, 21(2): 139-51.
6. Zhou, X.H., Wan Po, A.L. Peptide and protein drugs: II. Non-parentral routes of delivery. Int J Pharm 1991, 75: 117-30.
7. Lee, V.H.L., Kashi, S.D., Grass, G.M., Rubas, W. Oral peptide and protein drug delivery. In: Peptide and Protein Drug Delivery. Lee, V.H.L. (Ed.). Marcel Dekker, Inc.: New York 1991, 691-738.
8. Schnürch, A.B. Strategien zur peroralen applikation von peptidund proteinwirkstoffen. Sci Pharm 1997, 47: 113-21.
9. Junginger, H.E. Bioadhesive polymer systems for peptide delivery. Acta Pharm Technol 1990, 36: 110-26.
10. Lehr, C.M. Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract. Crit Rev Ther Drug 1994, 11: 119-60.
11. Schürch, A.B., Krajicek, M.E. Mucoadhesive polymers as platforms for peroral peptide delivery absorption: Synthesis and evaluation of different chitosan-EDTA conjugates. J Control Rel 1998, 50: 215-23.
12. Kitabchi, A.E., Fisher, J.N., Matteri, R., Murphy, M.B. The use of continuous insulin delivery systems in the treatment of diabetes mellitus. Adv Intern Med 1983, 28: 449-90.
13. Rytting, J.H. Rectal route of peptide and protein drug delivery. In: Peptide and Protein Drug Delivery. Lee, V.H.L. (Ed.). Marcel Dekker, Inc.: New York 1991, 579-93.
14. Sandow, J., Petri, W. Intranasal administration of peptides, biological activity and therapeutic efficacy. In: Transnasal Systemic Medications. Chien, Y.W. (Ed.). Elsevier Science: Amsterdam 1985, 183-99.
15. Harris, A.S. Biopharmaceutical aspects of the intranasal administration of peptides. In: Delivery Systems for Peptides. Davis, S.S., Illum, L., Tomilinson, E. (Eds.). Plenum Press: New York 1986, 191-204.
16. Su, K.S.E. Intranasal delivery of peptides and proteins. Pharm Int 1986, 7: 8-11.
17. Hermens, W.A.J.J., Thomas, N.W. The influence of drugs on nasal ciliary movement. Pharm Res 1987, 4: 445-9.
18. Chandler, S.G., Illeum, L., Thomas, N.W. Nasal absorption in the rat: II. Effects of enhancers on insulin absorption and nasal histology. Int J Pharm 1991, 76: 61-70.
19. Su, K.S.E. Nasal route for peptide and protein delivery. In: Peptide and Protein Drug Delivery. Lee, V.H.L. (Ed.) Marcel Dekker, Inc.: New York 1991, 595-631.
20. Merkle, H.P., Wolany, G. Buccal delivery for peptide drugs. J Control Rel 1992, 21: 155-64.
21. Merkle, H.P., Anders, R., Wermerskischan, A., Raehs, S., Wolany, G. Buccal route of peptide and protein drug delivery. In: Peptide and Protein Drug Delivery. Lee, V.H.L. (Ed.). Marcel Dekker, Inc.: New York 1991, 545-78.
22. Caldwell, L., Nishinata, T., Fix, J. et. al. Absorption-promoting adjuvants: Animal studies on their effects on rectal drug absorption. Rectal Therapy. Glas, B., de Blaey, C.J. (Eds.). Prous Science: Barcelona 1984, 57-61.
23. Lee, V.H.L. Changing needs in drug delivery in the era of peptide and protein drugs. In: Peptide and Protein Drug Delivery. Lee, V.H.L. (Ed.). Marcel Dekker, Inc.: New York 1991, 1-56.
24. Okada, H. Vaginal route of peptide and protein drug delivery. In: Peptide and Protein Drug Delivery. Lee, V.H.L. (Ed.). Marcel Dekker, Inc.: New York 1991, 633-66.
25. Li, V.H.K., Robinson, J.R., Lee, V.H.L. Influence of drug properties and routes of drug administration on the design of sustained and controlled release systems. In: Controlled Drug Delivery: Fundamentals and Applications, 2nd edition. Robinson, J.R., Lee, V.H.L. (Eds.). Marcel Dekker Inc.: New York 1987, 3-94.
26. Chien, Y.W. Transdermal Route of protein and peptide drug delivery. In: Peptide and Protein Drug Delivery. Lee, V.H.L. (Ed.). Marcel Dekker, Inc.: New York 1991, 667-89.
27. Pannatier, P.J., Testa, B., Etter, J.C. The skin as a drug metabolizing enzyme. Drug Metabol Rev 1978, 8: 319.
28. Singh, P., Maibach, H.I. Transdermal iontophoresis: Pharmacokinetic considerations. Clin Pharmacokinet 1994, 26: 327-34.
29. Chien, Y.W., Siddiqui, O., Shi, W.M., Lelawongs, P., Liu, J.C. Direct current iontophoretic transdermal delivery of peptide and protein drugs. J Pharm Sci 1989, 78: 376-83.
30. Chien, Y.W., Lelawongs, P., Siddiqui, O., Sun, Y., Shi, W.M. Facilitated transdermal delivery of therapeutic peptides and proteins by iontophoretic delivery devices. J Control Rel 1990, 13: 263-78.
31. Parasrampuria, D., Parasrampuria, J. Percutaneous delivery of proteins and peptides using iontophoretic techniques. J Clin Pharm Ther 16: 7-17.
32. Cullander, C., Guy, R.H. Transdermal delivery of peptides and proteins. Adv Drug Deliv Rev 1992, 8: 291-329.
33. Green, P.O. Iontophoretic delivery of peptide drug. J Control Rel 1996, 41: 33-48.
34. Stephen, R.L., Petelenz, T.J., Jacobsen, S.C. Potential novel methods for insulin administration I. Iontophoresis. Biomedical Biochemical Acta 1984, 43: 553-8.
35. Kari, B. Control of blood glucose levels in alloxan-diabetic rats by iontophoresis of insulin. Diabetes 1986, 35: 217-21.
36. Srinivasan, V., Higuchi, W.I., Sims, S.M., Ghanem, A.M., Behl, C.R. Transdermal iontophoretic drug delivery: Mechanistic analysis and application to polypeptide delivery. J Pharm Sci 1989, 78: 370-5.
37. Banga, A.J., Chien, Y.W. Hydrogel based iontophoretic delivery devices for transdermal delivery of peptide/protein drugs. Pharm Res 1992, 10: 697-702.
38. Zakzewski, C.A., Wasilewski, J., Cawley, P., Ford, W. Transdermal delivery of regular insulin to chronic diabetic rats. Effect of skin preparation and electrical enhancement. J Control Rel 1998, 50: 267-72.
39. Siddiqui, O., Sun, Y, Liu, J.C., Chien, Y.W. Facilitated transport of insulin. J Pharm Sci 1987, 76: 341-5.
40. Liu, J.C., Sun, Y., Siddiqui, O., Chien, Y.W., Shi, W.M., Li, J. Blood glucose control in diabetic rats by transdermal iontophoretic delivery of insulin. Int J Pharm 1988, 44: 197-204.
41. Meyer, B.R., Katzeff, H.L., Eschbach, J., Trimmer, J.S., Zacharias, S.B., Rosen, S., Sibalis, D. Transdermal delivery of insulin to albino rats using electrical current. Am J Med Sci 1989, 297: 321-5.
42. Lankjaer, L., Brange, J., Grodsky, G.M., Guy, R.H. Iontophoresis of monomeric insulin analogues in vitro: Effects of insulin charge and skin pretreatment. J Control Rel 1998, 51: 47-56.
43. Tomohira, Y., Machida, Y., Onishi, H., Nagai, T. Iontophoretic transdermal absorption of insulin and calcitonin in rats with newly devised switching technique and addition of urea. Int J Pharm 1997, 155: 231-9.
44. Rao, U.V., Misra, A.N. Enhancement iontophoretic permeation of insulin across human cadaver skin. Pharmazie 1994, 49: 538-9.
45. Rao, U.V., Misra, A.N. Comparative evaluation of the effect of penetration enhancers on passive diffusion and iontophoretic transport of insulin. Indian Drugs 1995, 32: 437-41.
46. Chandrasekhar, G., Bhat, R., Singh, M.K., Udupa, N. Optimization of parameters for transdermal permeation of insulin. Ind J Pharm Sci 1994, 56: 205-9.
47. Hao, J.S., Zhang, J.M., Yang, W.Z. Transdermal iontophoresis of insulin: Effect of penetration enhancers on blood glucose levels in diabetic rats. Acta Pharm Sinica Yao Hsueh Hsueh Pao 1995, 30: 776-80.
48. Huang, Y.Y., Wu, S.M. Stability of peptides during iontophoretic transdermal delivery. Int J Pharm 1996, 131: 19-23.
49. Miller, L.L., Kolaskie, C.J., Smith, G.A., Riviere, J.E. Transdermal iontophoresis of LHRH and two analogues. J Pharm Sci 1990, 79: 490-3.
50. Heit, M.C., Williams, P.L., Jayes, F.L., Chang, S.K., Riviere, J.E. Transdermal iontophoretic peptide delivery in vitro and in vivo studies with LHRH. J Pharm Sci 1993, 82: 240-3.
51. Heit, M.C., Riviere, M.N.B., Jayes, F.L., Riviere, J.E. Transdermal iontophoretic delivery of LHRH: Effect of repeated administration. Pharm Res 1994, 11: 1000-3.
52. Riviere, J.E., Riviere, M.N.A., Rogers, R.A., Bommannan, D., Tamada, J.A., Potts, R.O. Pulsatile transdermal delivery of LHRH using electroporation: Drug delivery and skin toxicology. J Control Rel 1995, 36: 229-33.
53. Bhatia, K.S., Singh, J. Synergistic effect of iontophoresis and a series of fatty acids on LHRH permeability through porcine skin. J Pharm Sci 1998, 87: 462-8.
54. Bommanan, D. B., Tamada, J., Leung , L., Potts, R.O. Effect of electroporation on transdermal iontophoresis of LHRH in vitro. Pharm Res 1994, 11: 1809-14.
55. Chen, L.L., Chien, Y.W. Transdermal iontophoretic permeation of luteinizing hormone releasing hormone: Characterization of electrical parameters. J Control Rel 1996, 40: 187-98.
56. Meyer, B.R, Kries, W., Eschbach, J., O'Maro, V., Rosen, S., Sibalis, D. Successful transdermal administration of therapeutic doses ofpolypeptide to normal human volunteers. Clin Pharmacol Ther 1988, 44: 607-12.
57. Meyer, B.R., Kries, W., Eschbach, J., O'Maro, V., Rosen, S., Sibalis, D. Transdermal versus subcutaneous leuprolide: A comparison of acute pharmacodynamic effect. Clin Pharmacol Ther 1990, 48: 340-5.
58. Lu, F.M., Lee, D., Carlson, R., Rao, G.S., Hsu, L. et al. Effects of formulation variables on transdermal iontophoretic delivery of leuprolide to humans. Drug Dev Ind Pharm 1993, 19: 1557-71.
59. Srinivasan, V., Su, M.H., Higuchi, W.I., Behl, C.R. Iontophoresis of polypeptides: Effect of ethanol pretreatment of human skin. J Pharm Sci 1990, 79: 588-91.
60. Hoogstrate, A.J., Srinivasan, V., Sims, S.M., Higuchi, W.I. Iontophoretic enhancement of peptides: Behavior of leuprolide versus model permeants. J Control Rel 1994, 31: 41-7.
61. Knoblauch, P., Moll, F. In vitro pulsatile and continuous transdermal delivery of buserelin by iontophoresis. J Control Rel 1993, 26: 203-12.
62. Charro, M.B.D., Guy, R.H. Iontophoretic delivery of nafarelin across the skin . Int J Pharm 1995, 117: 165-73.
63. Charro, M.B.D., Bayon, A.M.R., Guy, R.H. Iontophoresis of nafarelin: Effects of current density and concentration on electrotransport in vitro. J Control Rel 1995, 35: 35-40.
64. Bayon, A.M.R., Guy, R.H. Iontophoresis of nafarelin across human skin in vitro. Pharm Res 1996, 13: 798-800.
65. Morimoto, K., Iwakura, Y., Nakatani, E., Miyakai, M., Tojima, H. Effects of proteolytic enzyme inhibitors of absorption enhancers on the transdermal iontophoretic delivery of calcitonin in rats. J Pharm Pharmacol 1992, 44: 216-8.
66. Hager, D.F., Manonso, F.A., Nazareno, J.P., Sharkey, J.W. Evaluation of a cultured skin equivalent as a model for iontophoretic transport. J Control Rel 1994, 30: 117-23.
67. Santi, P., Colombo, P., Bettini, R., Catellani, P.L., Minutallo, A., Volpato, A.M. Drug reservoir composition and transport of salmon calcitonin in transdermal iontophoresis. Pharm Res 1997, 14: 63-6.
68. Thysman, S., Hanchard, C., Preat, V. Human calcitonin delivery in rats by iontophoresis. J Pharm Pharmacol 1994, 46: 725-30.
69. Iga, K., Okada, H., Matsumoto, Y. A matrix for iontophoresis. European patent application 643,981 A1, 20 September, 1994.
70. Lau, D.T.W., Sharkey, J.W., Petryk, L., Manarso, F.A., Yu, Z., Tse, F.L.S. Effect of current magnitude and drug concentration on iontophoretic delivery of octreotide acetate (Somatostatin[R]) in rabbits. Pharm Res 1994, 11: 1742-6.
71. Kumar, S., Char, H., Patel, S., Piemontesa, O., Malick, A.W., Iqbal, K., Neugroschal, E., Behl, C.R. In vitro transdermal iontophoretic delivery of growth hormone releasing factor CRF(1-44) in hairless guinea pigs. J Control Rel 1992, 18: 213-20.
72. Kumar, S., Char, H., Patel, S., Piemontesa, O., Malick, A.W., Iqbal, K., Nagroschal, E., Behl, C.R. Effect of iontophoresis on in-vitro permeation of an analogue of growth hormone releasing factor in hairless guinea pigs. J Pharm Sci 1992, 81: 635-9.
73. 3H]GHRP in rats. Int J Pharm 1997, 159: 1-11.
74. Lelawongs, P., Lui, J.C., Siddiqui, O., Chien, Y.W. Transdermal iontophoretic delivery of arginine vasopressin I. Physicochemical considerations. Int J Pharm 1989, 56: 13-22.
75. Lelawongs, P., Liu, J.C., Chien, Y.W. Transdermal iontophoretic delivery of vasopressin (II): Evaluation of electrical and operational factors. Int J Pharm 1990, 61: 179-88.
76. Iwakura, Y., Morimoto, K. Transdermal iontophoretic delivery of vasopressin and its analogues in rats. STP Pharma 1991, 1: 387-90.
77. Morimoto, K., Iwakura, Y., Miyazaki, M., Nakatani, E. Effect of proteolytic enzyme inhibitors on enhancement of transdermal iontophoretic delivery of vasopressin and an analogue in rats. Int J Pharm 1992, 81: 119-25.
78. Banga, A.K., Katam, M., Mitra, R. Transdermal iontophoretic delivery and degradation of vasopressin across human cadaver skin. Int J Pharm 1995, 115: 211-6.
79. Martin, M., Curley, P., Devane, J., Kelly, J. In vitro transdermal delivery of desmopressin. In: Prediction of Percutaneous Penetration. Scott, R.C., Guy, R.H., Hadgraft, J., Bodde, H.E. (Eds.). IBC Technical Services Ltd.: London 1991, 97-104.
80. Brady, A.B., Corish, J., Corrigan, O.I. Passive and electrically assisted transdermal delivery of desamino-8-D-arginovasopressin in vitro from a gel matrix. In: Prediction of Percutaneous Penetration. Scott, R.C., Guy, R.H., Hadgraft, J., Bodde, H.E. (Eds.). IBC Technical Services Ltd.: London 1991, 401-9.
81. Hinsberg, W.H.M.C.V., Bax, L., Flinterman, N.H.M., Verhoef, J., Junginger, H.E., Bodde, H.E. Iontophoresis of model peptide across human skin in vitro. Effect of iontophoresis protocol, pH and ionic strength on peptide flux and skin impedance. Pharm Res 1994, 11: 1296-1300.
82. Burnette, R.R., Marrero, D. Comparison between the iontphoretic and passive transport of TRH across excised nude mouse skin. J Pharm Sci 1986, 75: 738-43.
83. Sarpotdar, P.P., Daniels, C.R., Liversidge, G.G., Sternson, L.A. Facilitated iontophoretic mobility of TRH across cadaver skin by optimization of formulation variables. Pharm Res 1989, 6(Suppl): 107.
84. Jadoul, A., Hanchard, C., Thysman, S., Preat, V. Quantification and localization of fentanyl and TRH delivered by iontophoresis in the skin. Int J Pharm 1995, 120: 221-8.
85. Chou, W.L., Cheng, K.H., Yen, S.C., Jiang, T.S. The enhanced iontophoretic transport of TRH and its impedance study. Drug Dev Ind Pharm 1996, 22: 943-50.
86. Huang, Y.Y., Wu, S.M. Transdermal iontophoretic delivery of TRH across excised rabbit pinna skin. Drug Dev Ind Pharm 1996, 22: 1075-81.
87. Huang, Y.Y., Wu, S.M., Wang, C.Y. Response surface method: A novel strategy to optimize iontophoretic transdermal delivery of TRH. Pharm Res 1996, 13: 547-51.
88. Bhatia, K.S., Gao, S., Freeman, T.P., Singh, J. Effect of penetration enhancers and iontophoresis on the ultrastructure and cholecystokinin-8 permeability through porcine skin. J Pharm Sci 1997, 86: 1011-5.
89. Clemmesy, M., Courraze, G., Bevan, B., Puisieux, F. Mechanism involved in iontophoretic transport of angiotensin. Pharm Res 1995, 12: 998-1002.
90. Ruland, A., Rohr, U., Kreuter, J. Transdermal delivery of the tetrapeptide histeal (melanotropin (6-9)) and amino acids: Their contribution to the elucidation of the existence of an 'aqueous pore' pathway. Int J Pharm 1994, 107: 23-8.
91. Vutla, N.B., Betlageri, V., Banga, A.K. Transdermal iontophoretic delivery of enkephalin formulated in liposomes. J Pharm Sci 1996, 85: 5-8.
92. Chiang, C.H., Shao, C.H., Chen, J.L. Effects of pH, electric current and enzyme inhibitors on iontophoresis of delta sleep inducing peptide. Drug Dev Ind Pharm 1998, 24: 431-8.
93. Haak, R., Gupta, S.K. Pulsatile drug delivery from electrotransport therapeutics systems. In: Pulsatile Drug Delivery Current Applications and Future Trends. Gurny, R., Junginger, H.E., Peppas, N.A. (Eds.). Wiss., Verl.-Ges.: Stuttgart, Germany 1993, 99-112.
94. Yoshida, N.H., Roberts, M.S. Solute molecular size and transdermal iontophoresis across excised human skin. J Control Rel 1993, 25: 171-95.
95. Del Terzo, S., Behl, C.R., Nash, R.A. Iontophoretic transport of a homologous series of ionized and non-ionized model compounds: influence of hydrophobicity and mechanistic interpretation. Pharm Res 1989, 6: 85-90.
96. Green, P.G., Hinz, P.S., Szoke, F.C., Guy, R.H. Iontophoretic delivery of a series of tripeptides across the skin in-vitro. Pharm Res 1991, 8: 1121-7.
97. Oldenburg, K., Vo, K.T., Smith, G.A., Selick, H.E. Iontophoretic delivery of oligonucleotides across full thickness hairless mouse skin. J Pharm Sci 1995, 84: 915-21.
98. Hirvonen, J., Guy, R.H. Transdermal iontophoresis: modulation of electroosmosis by polypeptides. J Control Rel 1998, 50: 283-9.
99. Burnette, R.R., Ongpipattanakul, B. Characterization of the pore transport properties and tissue alteration of excised human skin during iontophoresis. J Pharm Sci 1988, 77: 132-7.
100. Sage, B.H., Bock, C.R., Denuzzio, J.D., Hoke, R.H. Technological and developmental issues of iontophoretic transport of peptide and protein drugs. In: Trends and Future Perspectives in Peptide and Protein Drugs. Lee, V.H.L., Hashida, M., Mizushima, Y. (Eds.). Harwood Publishers: Chur, Switzerland 1995, 111-34.
101. Choi, H.K., Flynn, F.L. Amidon, G.L. Transdermal delivery of bioactive peptides: The effect of N-decylmethylsulfoxide, pH and inhibitors on enkephalin metabolism and transport. Pharm Res 1990, 7: 1099-106.
102. Singh, D., Maibach, H.I. Iontophoresis in drug delivery: Basic principles and applications. Crit Rev Therap Drug Carrier Sys 1994, 11: 161-213.
103. Banga, A.K., Chien, Y.W. Iontophoretic delivery of drugs: Fundamentals, developments and biomedical applications. J Control Rel 1988, 7: 1-24.
104. Mazer, N.A. Pharmacological and biophysical considerations delivery: Input functions and routes of administration. J Pharm Sci 1989, 78: 885-7.
105. Mazer, N.A. Pharmacokinetics and pharmacodynamic aspects of polypeptide delivery. J Control Rel 1990, 11: 343-56.
106. Singh, P., Roberts, M.S., Maibach, H.I. Modeling of plasma levels of drugs following transdermal iontophoresis. J Control Rel 1995, 33: 293-8.
107. Wearley, L.L., Tojo, K., Chien, Y.W. A numerical approach to study the effect of binding on the iontophoretic transport of a series of amino acids. J Pharm Sci 1990, 79: 992-8.
108. Riviere, M.N.A. Altered epidermal morphology secondary to lidocame iontophoresis in vivo and in vitro studies in porcine skin. Fundam Appl Toxicol 1990, 15: 174-85.
109. Banga, A.K., Chien, Y.W. Systemic delivery of therapeutic peptides and proteins. Int J Pharm 1988, 48: 15-50.
110. Twardowski, Z.J., Noenh, K.D., McGray, T.J., Moore, H.L. Nature of insulin binding to plastic bags. Am J Hosp Pharm 1983, 40: 579-82.
111. Hill, J.B. Adsorption of insulin to bags. Proc Soc Exp Biol Med 1959, 102: 75-7.
112. Petty, C., Cunningham, N.L. Insulin adsorption by glass infusion bottles, polyvinyl chloride infusion containers and intravenous tubing. Anesthesiology 1974, 40: 400-4.
113. Mizutani, T., Mizutani, A. Prevention of adsorption of protein on controlled pore glass with amino acid buffer. J Chromatogr 1975, 111: 214-6.
114. Furberg, H., Jenson, A.K., Salbu, B. Effect of pretreatment with 0.9% sodium chloride or insulin solutions on the delivery of insulin from an infusion system. Am J Hosp Pharm 1986, 43: 2209-13.
115. Lloyd, L.B., Beck, J.E., Petelenz, T.J. Rehydratable product and method of preparation thereof. US patent 5,328,455, 12 July 1994.
116. Banga, A.K., Chien, Y.W. Characterization of in vitro transdermal iontophoretic delivery of insulin. Drug Dev Ind Pharm 1993, 19: 2069-87.
117. Phipps, J.P., Padmanabhan, R.V., Lattin, O.A. Iontophoretic delivery of model inorganic and drug ions. J Pharm Sci 1987, 78: 365-9.
118. Guy, R.H. A sweeter life for diabetics? Nature Med 1995, 1: 1132-3.
119. Kanikkanan, N., Singh, J., Rao, P.R. Transdermal iontophoretic delivery of bovine insulin and monomeric human insulin ana-logue. J Control Rel 1999, 59: 99-105.